MEDP vs IQV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

MEDP

42.3
AI Score
VS
IQV Wins

IQV

43.7
AI Score

Investment Advisor Scores

MEDP

42score
Recommendation
HOLD

IQV

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MEDP IQV Winner
Revenue 1.41B 4.15B IQV
Net Income 245.23M 274.00M IQV
Net Margin 17.3% 6.6% MEDP
Operating Income 288.33M 514.00M IQV
ROE 56.5% 4.4% MEDP
ROA 11.9% 0.9% MEDP
Total Assets 2.06B 29.68B IQV
Cash 502.69M 1.95B IQV
Current Ratio 0.73 0.75 IQV

Relative Price Performance (Last 90 Days)

MEDP 1M: -1.6% · 3M: +23.7% IQV 1M: +8.3% · 3M: +44.6%

Current Technical Phase

MEDP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $587.52

IQV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.5% over 20 days), RSI 61

RSI (14): 60.6 · Price: $261.77

Fundamentals Snapshot

Metric MEDP IQV
Market Cap
Forward P/E 30.4 18.1
Trailing P/E 34.5 32.2
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.1%
EPS 16.91 8.03
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IQV is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.